ABB robots leave the factory and target business opportunities in China's biopharmaceutical R&D and medical fields

More and more robots will no longer just stay on factory production lines, but will enter biomedical laboratories, hospitals, and even "work" with patients. ABB Group, a Swiss industrial giant one of the world's four largest robotics companies, recently opened its robot empowerment center focusing on the life sciences and medical industries in Zhangjiang Robot Valley, Shanghai. This move is ABB's second step in increasing investment in China's automation market after investing more than 1 billion yuan in building a robot super factory in Shanghai.

China is one of the world's largest and fastest-growing robotics markets, and is becoming the world's largest healthcare market. Ma Sikang, global president of ABB's robotics business, pointed out that the continuous development of industrial robots and artificial intelligence technology has brought more opportunities for automation in the life sciences and healthcare industries. Intelligent robots have the characteristics of high efficiency, high precision and anti-infection, and can help solve the challenges caused by the shortage of high-level medical talents. Through automation and digital technologies, the healthcare industry can not only improve efficiency and streamline processes, but also achieve more robust and agile operations

Prior to this, ABB had used robotic automation technology to change the way medication is dispensed in the inpatient pharmacy of Shanghai Seventh People’s Hospital. The automated pharmacy can sort 720 items of medication per hour. In ABB Robotics' laboratory at the Texas Medical Center in Houston, the United States, the robot system was able to increase the efficiency of neutralizing antibody detection from 15 times to 1,000 times a day, helping to alleviate the heavy pressure of new coronavirus testing at the time

Compared with other industries, the current overall level of automation in the biomedicine and medical industries is not high enough. Jose Manuel Collados, global head of the service robot product line of ABB Robotics Business Unit, told The Paper and other media that the medical and medical fields are significantly different from the traditional robot application market. The industry needs solutions that are not just robots or robotic arms, but also add analytical instruments, sensors or analytical software to existing robotics technology, such as machine learning functions or direct binding to some medical devices. This makes our work with the medical industry very unique and more difficult

The ABB Robotic Empowerment Center is located in Pudong, Shanghai. It will form the ABB global medical innovation network together with the healthcare research center at the Texas Medical Center in Houston, USA, and the research center in Frankfurt, Germany. He added

Wang Tong said that the scope of robot application has gradually advanced from the manufacturing side of pharmaceutical companies to the hospital side, and this process involves many automation implementation points

On the opening day, ABB Robotics signed a strategic cooperation agreement with Mettler Toledo, a global manufacturer of precision instruments and balancers, and Jingtai Technology, an artificial intelligence pharmaceutical company, to jointly develop innovative solutions for the medical industry. In addition, the empowerment center will also gather enterprises and universities to provide technical training based on laboratory scenarios and real-life on-site teaching to cultivate new talents.

The above is the detailed content of ABB robots leave the factory and target business opportunities in China's biopharmaceutical R&D and medical fields. For more information, please follow other related articles on the PHP Chinese website!